NASDAQ:ABDC - Alcentra Capital Stock Price, News & Analysis

Alcentra Capital trades on the NASDAQ under the ticker symbol "ABDC."

Alcentra Capital declared a quarterly dividend on Monday, August 5th. Shareholders of record on Thursday, September 26th will be paid a dividend of $0.18 per share on Thursday, October 3rd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 8.21%. The ex-dividend date of this dividend is Wednesday, September 25th. View Alcentra Capital's Dividend History.

Alcentra Capital declared that its Board of Directors has authorized a share repurchase plan on Friday, November 17th 2017, which authorizes the company to repurchase $2,500,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Shares repurchase plans are generally a sign that the company's leadership believes its shares are undervalued.

Alcentra Capital Corp (NASDAQ:ABDC) posted its quarterly earnings results on Wednesday, August, 7th. The asset manager reported $0.20 EPS for the quarter, beating analysts' consensus estimates of $0.20 by $0.00. The asset manager earned $6.14 million during the quarter, compared to analysts' expectations of $6.11 million. Alcentra Capital had a return on equity of 8.30% and a net margin of 31.91%. View Alcentra Capital's Earnings History.

Alcentra Capital is scheduled to release their next quarterly earnings announcement on Monday, November 4th 2019. View Earnings Estimates for Alcentra Capital.

Press coverage about ABDC stock has been trending negative on Tuesday, according to InfoTrie Sentiment. The research firm identifies positive and negative media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Alcentra Capital earned a news impact score of -2.9 on InfoTrie's scale. They also assigned news coverage about the asset manager a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for Alcentra Capital.

Alcentra Capital saw a decrease in short interest during the month of August. As of August 31st, there was short interest totalling 9,400 shares, a decrease of 40.9% from the July 31st total of 15,900 shares. Based on an average trading volume of 53,500 shares, the short-interest ratio is presently 0.2 days. Approximately 0.1% of the shares of the stock are sold short. View Alcentra Capital's Current Options Chain.

Some companies that are related to Alcentra Capital include Fidus Investment (FDUS), Westwood Holdings Group (WHG), Value Line (VALU), Saratoga Investment (SAR), Monroe Capital (MRCC), Silvercrest Asset Management Group (SAMG), StoneCastle Financial (BANX), Great Elm Capital (GECC), Hennessy Advisors (HNNA), Fifth Street Asset Management (FSAM), Manning and Napier (MN), U.S. Global Investors (GROW), Puhui Wealth Investment Managemnt (PHCF), Medley Management (MDLY) and BKF Capital Group (BKFG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Alcentra Capital investors own include Energy Transfer LP Unit (ET), SunCoke Energy Partners (SXCP), THL Credit (TCRD), Cornerstone Total Return Fund (CRF), Garrison Capital (GARS), Arlington Asset Investment (AI), Capitala Finance (CPTA), CBL & Associates Properties (CBL), NGL Energy Partners (NGL) and SandRidge Permian Trust (PER).

Alcentra Capital's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Bank of New York Mellon Corp (5.25%), Pacific Ridge Capital Partners LLC (3.55%), Morgan Stanley (3.41%), Oppenheimer & Co. Inc. (0.22%), Acadian Asset Management LLC (0.13%) and Appleton Partners Inc. MA (0.08%). Company insiders that own Alcentra Capital stock include Branko Krmpotic, David Scopelliti, Douglas J /Ma Greenlaw, Edward Grebow, Ellida Mcmillan, Paul J Echausse, Steven H Reiff, Suhail A Shaikh and T Ulrich Brechbuhl. View Institutional Ownership Trends for Alcentra Capital.

ABDC stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp and Oppenheimer & Co. Inc.. View Insider Buying and Selling for Alcentra Capital.

ABDC stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley, Pacific Ridge Capital Partners LLC, Appleton Partners Inc. MA and Acadian Asset Management LLC. Company insiders that have bought Alcentra Capital stock in the last two years include Branko Krmpotic, David Scopelliti, Douglas J /Ma Greenlaw, Edward Grebow, Ellida Mcmillan, Steven H Reiff, Suhail A Shaikh and T Ulrich Brechbuhl. View Insider Buying and Selling for Alcentra Capital.

Shares of ABDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ABDC stock can currently be purchased for approximately $8.77.

Alcentra Capital has a market capitalization of $112.92 million and generates $28.97 million in revenue each year. The asset manager earns $5.52 million in net income (profit) each year or $1.01 on an earnings per share basis. View Additional Information About Alcentra Capital.

The official website for Alcentra Capital is http://www.alcentracapital.com/.

Alcentra Capital's mailing address is 200 PARK AVENUE 7TH FLOOR, NEW YORK NY, 10166. The asset manager can be reached via phone at 212-922-8240 or via email at [email protected]